254 related articles for article (PubMed ID: 27576475)
41. Mapping of lateral pelvic lymph node recurrences in rectal cancer: a radiation oncologist's perspective.
Choi SH; Chang JS; Yoon HI; Jang DS; Kim NK; Lim JS; Min BS; Huh H; Shin SJ; Ahn JB; Koom WS
J Cancer Res Clin Oncol; 2018 Jun; 144(6):1119-1128. PubMed ID: 29546480
[TBL] [Abstract][Full Text] [Related]
42. Postoperative morbidity and mortality after mesorectal excision with and without lateral lymph node dissection for clinical stage II or stage III lower rectal cancer (JCOG0212): results from a multicentre, randomised controlled, non-inferiority trial.
Fujita S; Akasu T; Mizusawa J; Saito N; Kinugasa Y; Kanemitsu Y; Ohue M; Fujii S; Shiozawa M; Yamaguchi T; Moriya Y;
Lancet Oncol; 2012 Jun; 13(6):616-21. PubMed ID: 22591948
[TBL] [Abstract][Full Text] [Related]
43. Incidence and Predictive Model for Lateral Pelvic Lymph Node Metastasis in Lower Rectal Cancer.
Dev K; Veerenderkumar KV; Krishnamurthy S
Indian J Surg Oncol; 2018 Jun; 9(2):150-156. PubMed ID: 29887692
[TBL] [Abstract][Full Text] [Related]
44. [Clinic study of lateral lymph node metastasis in advanced lower rectal cancer].
Wu ZY; Wan J; Yao Y; Zhao G; Du JL; Yang J
Zhonghua Wai Ke Za Zhi; 2008 Feb; 46(3):190-2. PubMed ID: 18683713
[TBL] [Abstract][Full Text] [Related]
45. Risk factors for lateral pelvic lymph node metastasis in patients with lower rectal cancer: a systematic review and meta-analysis.
Zeng DX; Yang Z; Tan L; Ran MN; Liu ZL; Xiao JW
Front Oncol; 2023; 13():1219608. PubMed ID: 37746256
[TBL] [Abstract][Full Text] [Related]
46. Indication and benefit of pelvic sidewall dissection for rectal cancer.
Sugihara K; Kobayashi H; Kato T; Mori T; Mochizuki H; Kameoka S; Shirouzu K; Muto T
Dis Colon Rectum; 2006 Nov; 49(11):1663-72. PubMed ID: 17041749
[TBL] [Abstract][Full Text] [Related]
47. Feasibility of Extended Dissection of Lateral Pelvic Lymph Nodes During Laparoscopic Total Mesorectal Excision in Patients with Locally Advanced Lower Rectal Cancer: A Single-Center Pilot Study After Neoadjuvant Chemotherapy.
Aisu Y; Kato S; Kadokawa Y; Yasukawa D; Kimura Y; Takamatsu Y; Kitano T; Hori T
Med Sci Monit; 2018 Jun; 24():3966-3977. PubMed ID: 29890514
[TBL] [Abstract][Full Text] [Related]
48. Baseline MRI detected lateral lymph node as a prognostic factor: a cohort study in pN0 low-risk rectal cancer.
Sun RJ; Wang L; Li XT; Lu QY; Zhang XY; Guan Z; Sun YS
J Cancer Res Clin Oncol; 2020 Mar; 146(3):739-748. PubMed ID: 31832762
[TBL] [Abstract][Full Text] [Related]
49. [Lymph node dissection after primary surgery and neoadjuvant radiochemotherapy of rectal cancer. Interim analysis of a multicenter prospective observational study (OCUM)].
Kreis ME; Maurer CA; Ruppert R; Ptok H; Strassburg J; Junginger T; Merkel S; Hermanek P
Chirurg; 2015 Dec; 86(12):1132-7. PubMed ID: 26223668
[TBL] [Abstract][Full Text] [Related]
50. Controversies in the Management of Lateral Pelvic Lymph Nodes in Patients With Advanced Rectal Cancer: East or West?
Otero de Pablos J; Mayol J
Front Surg; 2019; 6():79. PubMed ID: 32010707
[TBL] [Abstract][Full Text] [Related]
51. Lateral lymph node metastasis is a major cause of locoregional recurrence in rectal cancer treated with preoperative chemoradiotherapy and curative resection.
Kim TH; Jeong SY; Choi DH; Kim DY; Jung KH; Moon SH; Chang HJ; Lim SB; Choi HS; Park JG
Ann Surg Oncol; 2008 Mar; 15(3):729-37. PubMed ID: 18057989
[TBL] [Abstract][Full Text] [Related]
52. Morphological criteria for metastatic mesorectal lymph nodes in rectal cancer.
Matsuoka H; Masaki T; Kobayashi T; Sato K; Sugiyama M; Atomi Y; Ohkura Y
Hepatogastroenterology; 2009; 56(96):1661-4. PubMed ID: 20214213
[TBL] [Abstract][Full Text] [Related]
53. A Nomogram to Predict Lymph Node Positivity Following Neoadjuvant Chemoradiation in Locally Advanced Rectal Cancer.
Newton AD; Li J; Jeganathan AN; Mahmoud NN; Epstein AJ; Paulson EC
Dis Colon Rectum; 2016 Aug; 59(8):710-7. PubMed ID: 27384088
[TBL] [Abstract][Full Text] [Related]
54. [Three Cases of Stage Ⅳ Low Rectal Cancer with Lateral Pelvic Lymph Node Metastasis].
Tamura H; Shimada Y; Yagi R; Tajima Y; Okamura T; Nakano M; Ishikawa T; Sakata J; Kobayashi T; Kameyama H; Kosugi S; Wakai T; Nogami H; Maruyama S; Takii Y
Gan To Kagaku Ryoho; 2015 Nov; 42(12):2303-5. PubMed ID: 26805345
[TBL] [Abstract][Full Text] [Related]
55. Chemical shift effect predicting lymph node status in rectal cancer using high-resolution MR imaging with node-for-node matched histopathological validation.
Zhang H; Zhang C; Zheng Z; Ye F; Liu Y; Zou S; Zhou C
Eur Radiol; 2017 Sep; 27(9):3845-3855. PubMed ID: 28168369
[TBL] [Abstract][Full Text] [Related]
56. Lateral lymph-node dissection for rectal cancer: meta-analysis of all 944 cases undergoing surgery during 1975-2004.
Kinugasa T; Akagi Y; Ochi T; Ishibashi Y; Tanaka N; Oka Y; Mizobe T; Yuge K; Fujino S; Kibe S; Shirouzu K
Anticancer Res; 2013 Jul; 33(7):2921-7. PubMed ID: 23780981
[TBL] [Abstract][Full Text] [Related]
57. A case report of the transanal lateral lymph node dissection with a combined abdominal assisted approach for the lower rectal cancer.
Ishii M; Nitta T; Kataoka J; Iida R; Ueda Y; Senpuku S; Matsutani A; Yamamoto M; Ishibashi T; Okuda J
Ann Med Surg (Lond); 2022 Jan; 73():103173. PubMed ID: 34976391
[TBL] [Abstract][Full Text] [Related]
58. Clinical relevance of morphologic MRI criteria for the assessment of lymph nodes in patients with rectal cancer.
Doyon F; Attenberger UI; Dinter DJ; Schoenberg SO; Post S; Kienle P
Int J Colorectal Dis; 2015 Nov; 30(11):1541-6. PubMed ID: 26260478
[TBL] [Abstract][Full Text] [Related]
59. Diagnostic accuracy of magnetic resonance imaging and computed tomography for lateral lymph node metastasis in rectal cancer: a systematic review and meta-analysis.
Hoshino N; Murakami K; Hida K; Sakamoto T; Sakai Y
Int J Clin Oncol; 2019 Jan; 24(1):46-52. PubMed ID: 30259217
[TBL] [Abstract][Full Text] [Related]
60. Lateral pelvic lymph nodes for rectal cancer: A review of diagnosis and management.
Ogawa S; Itabashi M; Inoue Y; Ohki T; Bamba Y; Koshino K; Nakagawa R; Tani K; Aihara H; Kondo H; Yamaguchi S; Yamamoto M
World J Gastrointest Oncol; 2021 Oct; 13(10):1412-1424. PubMed ID: 34721774
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
